N/A Completed N=36 Randomized Single-blind Treatment

Brief Acceptance-Based Retention Intervention for Newly Diagnosed HIV Patients

Source: ClinicalTrials.gov NCT04201288 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Oct 2025

Primary outcomePrimary: Number of Participants Meeting Retention in HIV Medical Care Guidelines at 52 Weeks — 20; 16 Participants

Summary

The overall aim of this program of research is to test a newly developed intervention, Acceptance-Based Behavior Therapy (ABBT), to improve HIV patients' commitment to medical care. The purpose of the proposed project is to establish the efficacy of ABBT and examine its mechanisms of action. To achieve the specific aims, the investigators will conduct a randomized clinical trial (n = 270), with two treatment arms: ABBT vs. an attention-matched HIV education control condition.

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Participants Meeting Retention in HIV Medical Care Guidelines at 52 Weeks	20; 16	—
PRIMARY Number of Participants Who Met HIV Virologic Suppression	20; 14	—
SECONDARY Self-Rating Scale Item (SRSI) - Antiretroviral Treatment Adherence	4.5; 4.6	—
SECONDARY Brief HIV Disclosure Scale (BHD)	21.3; 22.1	—
SECONDARY The Multidimensional Scale of Perceived Social Support (MSPSS)	5.8; 5.3	—
SECONDARY HIV Stigma Scale (HSS)	19.5; 21.1	—

Eligibility Criteria

Inclusion Criteria

HIV+
≥18 years old
Entering HIV medical care services for the first time (that is, not transferring HIV care from another location)
Able to speak and read English at the level to be able to complete the study procedures
Have telephone access.

Exclusion Criteria

Cognitively impaired

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04201288). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.